Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000666 | Ellagic acid | 0.71 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Purine | 0.77 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Histidine | 0.83 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | L-Serine | 0.84 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | PROTOVERATRINE A | 0.85 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | B-ureidoisobutyric acid | 0.88 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | ISOEUGENITOL | 0.9 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Methylglyoxal | 0.9 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Lactic acid | 0.9 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-Hydroxyadipic acid | 0.9 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Proline | 0.97 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Purine - 1.1767727 | 1.18 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | isoamyl nitrite | 1.18 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 20alpha-Dihydroprogesterone glucuronide | 1.19 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Uridine | 1.21 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Uric acid | 1.23 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | alpha-Hydroxytriazolam | 1.26 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Dihydroxyacetone (glycerone) | 1.27 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 3-Amino-3-(4-hydroxyphenyl)propanoate | 1.68 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Isoleucine | 2.07 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | O-Desmethylnaproxen | 2.27 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | a-hydroxybutyrate | 2.28 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Leucine | 2.3 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | O-Desmethylnaproxen - 2.6897879 | 2.69 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | a-hydroxybutyrate - 2.692548 | 2.69 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Ellagic acid - 3.0870278 | 3.09 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Phosphoglycolic acid | 3.17 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-amino-4'-hydroxy-Propiophenone | 3.17 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Pyrocatechol sulfate | 3.55 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Phosphoglycolic acid - 3.6416552 | 3.64 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Glucoheptonic acid | 3.64 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Indole | 3.64 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Tryptophan | 3.64 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | D-Glucose | 3.67 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 3-Methyl-2-oxovaleric acid | 3.69 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Tetrahydrofuran | 3.74 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Phenol | 3.84 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 4-Hydroxybenzenesulfonic acid | 3.84 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 3-Methyl-2-oxovaleric acid - 3.8886838 | 3.89 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Indoxylsulfuric acid | 4.11 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | N-gamma-Acetyl-N-2-formyl-5-methoxykynurenamine | 4.32 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Hippuric acid | 4.34 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2,3-Dihydroxybenzoic acid | 4.4 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Benzyl alcohol | 4.8 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5-Methoxyindoleacetate | 5.34 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 3-Methylsuberic acid | 5.75 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Isoquinoline N-oxide | 5.76 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 19-hydroxy-17-oxoandrost-5-en-3-beta-yl sulfate | 5.91 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5beta-Androstan-3alpha-ol-17-one sulfate | 6.37 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Met His Lys | 6.42 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Arg Ser Phe | 6.69 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Testosterone sulfate | 7.01 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 17a-Ethynylestradiol 2-glucuronide | 7.01 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5beta-Androstan-3alpha-ol-17-one sulfate - 7.173876 | 7.17 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Pregnanolone sulfate | 7.2 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5beta-Androstan-3alpha-ol-17-one sulfate - 7.3669353 | 7.37 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 3a,7b,12a-Trihydroxyoxocholanyl-Glycine | 7.61 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-Hydroxy-3-(4-methoxyethylphenoxy)-propanoic acid | 7.72 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-ISOPRENYL-3-HYDROXY-5-METHYL-a-PYRONE | 8.32 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Glycoursodeoxycholic acid | 8.63 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Glycoursodeoxycholic acid - 8.836754 | 8.84 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | methyl 9,11-epidioxy-12,15-dihydroperoxy-5,7,13-eicosatrienoate | 8.99 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Embelin | 8.99 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | thyrotropin releasing hormone | 8.99 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | KOBUSONE | 8.99 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Ser His His | 9 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | gamma-Hydroxyphenylbutazone glucuronide | 9.58 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Embelin - 9.617185 | 9.62 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | O-BENZYL-l-SERINE | 9.63 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5-(4-hydroxy-2,5-dimethylphenoxy)-2,2-dimethyl-Pentanoic acid (Gemfibrozil M1) | 9.64 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Gln Trp Gln | 9.67 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Tyr Arg Leu | 10.03 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-Hydroxyethinylestradiol | 10.06 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 6b,11b,16a,17a,21-Pentahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide | 10.11 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Murocholic acid - 10.139921 | 10.14 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-Hydroxyethinylestradiol - 10.176795 | 10.18 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | cyclandelate | 10.33 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-Hydroxyethinylestradiol - 10.331066 | 10.33 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Arg Phe Arg | 10.47 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Isoacitretin | 10.57 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Desmosine | 10.58 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Glu Tyr Thr | 10.66 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | clavulone I | 10.66 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Fexofenadine | 10.66 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Arg Phe Arg - 10.677579 | 10.68 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Isoacitretin - 10.747422 | 10.75 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-24-oxovitamin D_3 / 1alpha,25-dihydroxy-24-oxocholecalciferol | 10.76 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | clavulone I - 10.765902 | 10.77 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Sodium tetradecyl sulfate | 10.85 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Isoacitretin - 10.9078665 | 10.91 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | D1-2-Hydroxymethylethisterone | 11.15 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | TRIDESACETOXYKHIVORIN | 11.21 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | D1-2-Hydroxymethylethisterone - 11.279384 | 11.28 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Gemfibrozil M2 | 11.33 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Val Arg Phe | 11.38 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | D1-2-Hydroxymethylethisterone - 11.426857 | 11.43 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | D1-2-Hydroxymethylethisterone - 11.506317 | 11.51 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Lauric acid | 11.9 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Panaxytriol | 12.06 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 8R-hydroxy-9Z-octadecenoic acid | 12.16 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | DL-12-hydroxy stearic acid | 12.19 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 9R-hydroxy-12E-octadecenoic acid | 12.56 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,18-dihydroxyvitamin D_3 / 1alpha,18-dihydroxycholecalciferol | 12.62 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-2beta-(5-hydroxypentoxy)vitamin D3 / 1alpha,25-dihydroxy-2beta-(5-hydroxypentoxy | 12.67 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Lys Trp Arg | 12.74 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 4'-Apo-3,4-didehydrolycopene/ (4-Apo-3',4'-didehydrolycopene) | 12.78 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Murocholic acid | 12.82 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 9,12,14-octadecatrienoic acid | 12.84 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 9,12,14-octadecatrienoic acid - 12.930276 | 12.93 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Murocholic acid - 12.997159 | 13 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 3,9,15-Docosatriynoic acid | 13.1 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 4,8-dimethyl-dodecanoic acid | 13.13 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 7-palmitoleic acid | 13.29 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 4Z,7Z,10Z,13Z-eicosatetraenoic acid | 13.33 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Embelin - 13.489656 | 13.49 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 13E,17-octadecadienoic acid | 13.51 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Arg Asn Gln | 13.52 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-2beta-(5-hydroxypentoxy)vitamin D3 / 1alpha,25-dihydroxy-2beta-(5-hydroxypentoxy - 13.600336 | 13.6 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 13E,17-octadecadienoic acid - 13.613921 | 13.61 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 4,7,10,13,16-docosapentaenoic acid | 13.62 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Embelin - 13.636872 | 13.64 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1,2-di-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycerol | 13.65 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-26,27-dimethyl-22-oxavitamin D3 / 1alpha,25-dihydroxy-26,27-dimethyl-22-oxachole | 13.65 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | (22S)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a,24b-dihomo-20-epivitamin D3 / (22S)-1alpha,22,2 | 13.66 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Teasterone | 13.67 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Castasterone | 13.7 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-26,27-dimethyl-22-oxavitamin D3 / 1alpha,25-dihydroxy-26,27-dimethyl-22-oxachole - 13.704973 | 13.7 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Teasterone - 13.719101 | 13.72 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-Hydroxyethinylestradiol - 13.766247 | 13.77 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5Z,11Z,14Z-eicosatrienoic acid | 13.77 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-26,27-dimethyl-22-oxavitamin D3 / 1alpha,25-dihydroxy-26,27-dimethyl-22-oxachole - 13.802342 | 13.8 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 4,7,10,13-docosatetraenoic acid | 14.01 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Loroxanthin ester/ Loroxanthin dodecenoate | 14.05 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-propyl-tridecanoic acid | 14.08 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Teasterone - 14.130692 | 14.13 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Embelin - 14.135789 | 14.14 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))[iso6] | 14.15 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-11alpha-phenylvitamin D3 / 1alpha,25-dihydroxy-11alpha-phenylcholecalciferol | 14.16 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | PRISTIMEROL | 14.16 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Isoacitretin - 14.180219 | 14.18 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Arg Ala Phe | 14.18 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Monensin | 14.19 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Embelin - 14.246171 | 14.25 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5-octadecylenic acid | 14.26 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 5-octadecylenic acid - 14.302397 | 14.3 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))[iso6] - 14.429592 | 14.43 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Stearic acid | 14.52 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Hexacosanedioic acid | 14.55 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Loroxanthin ester/ Loroxanthin dodecenoate - 14.5606 | 14.56 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))[iso6] - 14.669076 | 14.67 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 2-propyl-tridecanoic acid - 14.683501 | 14.68 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1-(13Z-docosenoyl)-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol | 14.7 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 10-methyl-hexadecanoic acid | 14.71 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Embelin - 14.705376 | 14.71 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | 1alpha,25-dihydroxy-11alpha-phenylvitamin D3 / 1alpha,25-dihydroxy-11alpha-phenylcholecalciferol - 14.712189 | 14.71 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Isoarachidic acid | 14.72 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000666 | Bilirubin | 14.77 | Minutes | ST000421 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood |
